Related Experiment Video
Updated: Aug 2, 2025

07:56
Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells
Published on: November 16, 2018
6.9K
Exploring microRNAs in craniofacial regenerative medicine
Dan Su1,2, Samuel Swearson1, Tadkamol Krongbaramee3,4
1Department of Anatomy and Cell Biology, The University of Iowa, Iowa City, IA, U.S.A.
Biochemical Society Transactions
|April 19, 2023
Summary
MicroRNAs (miRs) are key regulators of bone development and regeneration. This review explores their therapeutic potential for craniofacial bone defects, addressing delivery challenges and comparing various miR-based strategies for oral tissue repair.
Area of Science:
- Regenerative Medicine
- Molecular Biology
- Craniofacial Development
Background:
- MicroRNAs (miRs) are critical regulators of bone development and regeneration, influencing stem cell maintenance and fate.
- miRs hold therapeutic promise for craniofacial bone defects by modulating stem cell behavior.
- Translating miR-based therapies to clinical practice faces challenges in efficiency, specificity, efficacy, and delivery system safety.
Approach:
- Comparison of therapeutic miR oligonucleotides, mimics, and antagomirs for disease treatment and tissue regeneration.
- Evaluation of novel technologies for miR expression or inhibition in oral tissue repair.
- Analysis of extracellular vesicles and nanoparticles as delivery vehicles for miRs, considering their composition-dependent effects.
Key Points:
- Assessment of specificity, toxicity, stability, and effectiveness of various miR systems in regenerative medicine.
- Discussion of challenges and advancements in miR manipulation for therapeutic applications.
- Focus on oral tissue regeneration and repair using miR-based strategies.
Conclusions:
- miRs represent a promising avenue for craniofacial bone defect treatment and oral tissue regeneration.
- Optimizing miR delivery systems and manipulation methods is crucial for clinical translation.
- Further research into the specificity, safety, and efficacy of miR-based therapies is warranted.

